Argentina Diabetes Devices Market to Worth Over US$ 1,031.89 Million by 2033 | Astute Analytica [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Indonesia's automotive financing accelerates amid surging consumer aspirations, resilient credit systems, and rapidly evolving digital loan platforms, fueling a remarkable dual-market trajectory. New Delhi, Jan. 01, 2025 (GLOBE NEWSWIRE) -- According to the latest study from Astute Analytica, the Argentina diabetes devices market is projected to hit the market valuation of US$ 1,031.89 million by 2033 from US$ 539.12 million in 2024 at a CAGR of 7.48% during the forecast period 2025–2033. Argentina has emerged as a pivotal market for innovative diabetes devices, driven by rising awareness campaigns and ongoing medical advancements. According to the Argentine Society of Diabetes, 47% of diabetes patients in the country reported heightened interest in next-generation glucose monitors in 2024, reflecting a notable shift from conventional testing methods. In the same period, 38% of endocrinologists in Buenos Aires recommended continuous glucose monitoring (CGM) systems for type 2 diab
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Evercore ISI to $136.00. They now have a "buy" rating on the stock.MarketBeat
- Abbott Hosts Conference Call for Fourth-Quarter EarningsPR Newswire
- A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT) [Yahoo! Finance]Yahoo! Finance
- Antimicrobial Resistance Diagnostic Markets, Strategies and Trends Report 2024 with Executive Guides and 5 Year Forecasts [Yahoo! Finance]Yahoo! Finance
- Molecular Diagnostics at the Point of Care Research Report with Executive Guides and Analysis [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/16/24 - Beat
ABT
Sec Filings
- 1/3/25 - Form 4
- 1/3/25 - Form 4
- 1/3/25 - Form 4
- ABT's page on the SEC website